entertainment -WSS

entertainment

author：knowledge 2025-09-30 00:47:49 - browse：98375

Courtesy Guardant Health

An independent panel of advisers to the Food and Drug Administration recommended the agency approve Guardant Health’s blood-based colon cancer detection test. If the agency follows the recommendation, it will clear an early hurdle for the test’s broader adoption.

The expert panel spent hours listening to presentations from Guardant, the FDA, and members of the public before voting on the screening test, called Shield. The panel’s nine voting members then voted on whether the test was safe, effective, and whether its benefits outweigh its risks, with eight, six, and seven panelists endorsing those views, respectively.

FDA approval is a requirement for winning coverage from the Centers for Medicare and Medicaid Services, which could be the difference between Guardant’s test becoming widespread — or irrelevant. In 2021, CMS denied coverage for Epi proColon, a different blood-based colon cancer test approved by the FDA. Soon after, the test’s maker, Epigenomics, announced that it would stop actively marketing the test, and last year the company announced a restructuring that included layoffs.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Blinken talks high

WSS

France's anti

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Providers still hesitate to prescribe buprenorphine, study finds

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

France's anti

Body of missing toddler recovered in Delaware River days after flood: Police

knowledge

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Supreme Court strikes down use of affirmative action

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Providers still hesitate to prescribe buprenorphine, study finds

DIEP, the 'gold standard' of breast reconstruction, is under threat

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Virginia high school admissions case could be legal follow

Antibody drugs appear effective. Now can we make enough of them?

entertainment

The debate over Covid

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Why an extreme heat and wildfire smoke combination can be so dangerous

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Watch the official trailer for 'Ahsoka' series

focus

focus

knowledge

Wikipedia